Skip to main content

Stigmabase | HIV

Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

| |

Analysis of 9vHPV Vaccination Benefits in Men With HIV

South Africa Time — Thursday, February 26, 2026

Mixed vaccine impact means MSM with HIV still need ongoing anal cancer screening.

View article...

Racial Xperience

Top stories of the last 30 days

New approach to HIV treatment offers hope to reduce daily drug needs

South Africa Time — Thursday, February 05, 2026

More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the ... View article...

Digital health system boosts family planning, HIV services in rural areas

South Africa Time — Thursday, February 05, 2026

... HIV /AIDS education at community level. "Family planning enables individuals and couples to make informed choices, and the access expansion to ... View article...

Wistar Scientists Demonstrate First-Ever Single-Shot HIV Vaccine Neutralization Success

South Africa Time — Thursday, February 05, 2026

Scientists at The Wistar Institute have developed an HIV vaccine candidate that induces neutralizing antibodies against HIV after a single ... View article...

First of its kind daily HIV treatment shows promising results

South Africa Time — Monday, February 09, 2026

All of the currently recommended HIV treatment regimens include an integrase strand-transfer inhibitor (INSTI) – a drug that blocks the integration of ... View article...

HIV drug's Medicare costs under negotiation

South Africa Time — Monday, February 02, 2026

The government will negotiate the price of Biktarvy with drugmaker Gilead Sciences. bottle of HIV suppressing drug Biktarvy. The Centers for Medicare ... View article...

Black HIV / AIDS awareness

South Africa Time — Thursday, February 05, 2026

“Black men are twelve times more likely to be HIV -positive than white men,” said advocate Creola Hampton, “and there are fourteen times more Black ... View article...

Effects of Digital Health Interventions to Promote Safer Sex Behaviors Among Youth

South Africa Time — Wednesday, February 04, 2026

... HIV /STIs incidence, rank modalities using Bayesian network meta-analysis (NMA), and position their effectiveness relative to NDIs. Methods: A ... View article...

HIV is on the rise in the Blue Ridge Health District. There's a way to stop it.

South Africa Time — Monday, February 02, 2026

In the past year, HIV infections have increased 64% in the Blue Ridge Health District. The number is made all the more troubling by the existence ... View article...

JOHANNESBURG

Stigmabase is a canadian non-profit internet initiative dedicated to informing and raising awareness on the damaging effects of social exclusion and stigma around the world. The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

Powered by Blogger

2010 - 2026 ― Stigmabase Global Initiative || Keeping up-to-date on global exclusion

Top stories of the last 7 days

Breakthrough anti-HIV drug "lenacapavir" by Gilead Sciences deployed in African countries

South Africa Time — Wednesday, February 25, 2026

Zimbabwe has taken a groundbreaking step in its fight against HIV by launching the administration of lenacapavir, a long-acting injectable HIV ... View article...

Kenya becomes first in East Africa to launch six-month HIV prevention injection

South Africa Time — Thursday, February 26, 2026

Years later, Mutua, now 27, has become the first Kenyan to receive lenacapavir, a new injectable option that protects against HIV for six months with ... View article...

Tributes for 'tenacious campaigner' who set up leading HIV charity

South Africa Time — Monday, February 23, 2026

Tributes have been paid to the founder of a leading HIV /Aids charity who has died, aged 71. Newport-born Martyn Butler co-founded the Terrence ... View article...

What's New In HIV Treatment?

South Africa Time — Monday, February 23, 2026

Immunotherapies aim to boost the immune system's ability to recognize and eliminate HIV -infected cells, potentially leading to a functional cure where ... View article...

Double-negative T Cells in Pediatric HIV and Their Impact on Disease Progression

South Africa Time — Thursday, February 26, 2026

Immune reconstitution in pediatric HIV infection under antiretroviral therapy (ART) is monitored by CD4 + T-cell counts and the CD4/CD8 ratio, ... View article...

Checkpoint Inhibitors Work Well for HIV-Positive People With Cancer

South Africa Time — Monday, February 23, 2026

Checkpoint immunotherapy is a breakthrough in cancer treatment—and it may also promote HIV remission. View article...

When On-Target Misses the Mark: Lessons from HIV Immunogens

South Africa Time — Monday, February 23, 2026

The target of the HIV vaccine is the surface glycoprotein Env, which initiates viral entry into host cells and is blocked by neutralizing antibodies. View article...

ABOUT STIGMABASE
Request for Review

Total Pageviews